3 citations
,
November 2021 in “Frontiers in Medicine” Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.
2 citations
,
August 2020 in “Journal of The American Academy of Dermatology” High incidence of hair loss found in COVID-19 patients, but no severity correlation established.
1 citations
,
April 2020 in “Magnetic Resonance in Medical Sciences” MRI helps evaluate androgenetic alopecia severity.
1 citations
,
December 2018 in “Journal of Cosmetic Dermatology” Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.
January 2026 in “Jurnal Akta Trimedika” Microneedling with PRP effectively improved hair growth and thickness in androgenic alopecia without side effects.
January 2025 in “International Journal of Trichology” Severe hair loss may increase the risk of dying from COVID-19.
January 2024 in “International Ayurvedic medical journal” Certain Prakruti types are more prone to early male pattern baldness.
August 2023 in “Journal of Cosmetic Dermatology” Using a laser with minoxidil was more effective for hair loss than minoxidil alone.
May 2023 in “Bali Medical Journal” Higher sebum levels are linked to more severe male baldness.
April 2023 in “Pakistan Journal of Medical and Health Sciences” Platelet rich plasma treatment is effective for hair loss in both men and women.
Platelet-rich plasma injections effectively treat hair loss in both men and women, increasing hair density with high patient satisfaction and no significant side effects.
October 2013 in “Journal of the American College of Cardiology” Men with male pattern baldness have increased arterial stiffness.
December 2022 in “Pakistan Armed Forces Medical Journal” Androgenetic alopecia may increase the severity of COVID-19.
December 2021 in “Biomarkers” Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.
October 2021 in “DOAJ (DOAJ: Directory of Open Access Journals)” Trichoscopy effectively distinguishes between severe and mild male pattern hair loss.
Androgenetic alopecia may be linked to severe COVID-19.
Most severe COVID-19 patients had hair loss, suggesting a possible link.
August 2019 in “Journal of The American Academy of Dermatology” No link found between hair loss severity and PSA levels in men.
January 2018 in “프로그램북(구 초록집)” No link between hair loss severity and PSA levels in men.
January 2017 in “IP Indian journal of clinical and experimental dermatology” Early-onset male baldness is not linked to insulin resistance, but is significantly associated with metabolic syndrome.
July 2016 in “IP Indian journal of clinical and experimental dermatology” PRP is effective in treating male pattern baldness.
January 2020 in “International journal of scientific research” Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.
January 2021 in “Skinmed” CEOs aged 50-69 have less significant hair loss than the general white male population.
CEOs aged 50-69 have less significant hair loss than the general white male population.
PRP with microneedling is more effective than PRP alone for treating hair loss.
February 1998 in “Journal of Investigative Dermatology” Men often see themselves as balder than experts do.
July 2007 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.
November 2009 in “Hair transplant forum international” Dr. Bernard Cohen created a new system to classify hair loss using numbers and a detailed scalp map.
December 2025 in “Journal of Pharmacy And Bioallied Sciences” Personalized Ayurvedic treatment can effectively regrow hair in androgenetic alopecia.
March 2026 in “Pakistan Armed Forces Medical Journal” Trichoscopy is useful for diagnosing and assessing androgenetic alopecia severity.